Cargando…

A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trial

A conditionally replication-defective human cytomegalovirus (HCMV) vaccine, V160, was shown to be safe and immunogenic in a two-part, double-blind, randomized, placebo-controlled phase I clinical trial (NCT01986010). However, the specificities and functional properties of V160-elicited antibodies re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Leike, Freed, Daniel C., Liu, Yaping, Li, Fengsheng, Barrett, Diane F., Xiong, Wei, Ye, Xiaohua, Adler, Stuart P., Rupp, Richard E., Wang, Dai, Zhang, Ningyan, Fu, Tong-Ming, An, Zhiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172929/ https://www.ncbi.nlm.nih.gov/pubmed/34078915 http://dx.doi.org/10.1038/s41541-021-00342-3

Ejemplares similares

Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infection
por: Valencia, Sarah M., et al.
Publicado: (2023)

Potent Bispecific Neutralizing Antibody Targeting Glycoprotein B and the gH/gL/pUL128/130/131 Complex of Human Cytomegalovirus
por: Su, Hang, et al.
Publicado: (2021)

Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas
por: Tabata, Takako, et al.
Publicado: (2019)

Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody
por: Meng, Weixu, et al.
Publicado: (2017)

Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes
por: Li, Leike, et al.
Publicado: (2019)

Phase 1 Clinical Trial of a Replication-Defective Human Cytomegalovirus (CMV) Vaccine
por: Adler, Stuart, et al.
Publicado: (2017)

Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination
por: Li, Fengsheng, et al.
Publicado: (2017)

Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection
por: Ye, Xiaohua, et al.
Publicado: (2019)

Active evolution of memory B-cells specific to viral gH/gL/pUL128/130/131 pentameric complex in healthy subjects with silent human cytomegalovirus infection
por: Xia, Lin, et al.
Publicado: (2017)

Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment step
por: Ye, Xiaohua, et al.
Publicado: (2020)

Functionally inactivated dominant viral antigens of human cytomegalovirus delivered in replication incompetent adenovirus type 6 vectors as vaccine candidates
por: Tang, Aimin, et al.
Publicado: (2017)

Structural basis for HCMV Pentamer recognition by neuropilin 2 and neutralizing antibodies
por: Wrapp, Daniel, et al.
Publicado: (2022)

Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies
por: Ai, Yuanbao, et al.
Publicado: (2022)

Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cells
por: Meng, Weixu, et al.
Publicado: (2015)

Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex
por: Ha, Sha, et al.
Publicado: (2017)

Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells
por: Funaro, Ada, et al.
Publicado: (2008)

Immunization with Human Cytomegalovirus Core Fusion Machinery and Accessory Envelope Proteins Elicit Strong Synergistic Neutralizing Activities
por: Cui, Xinle, et al.
Publicado: (2020)

Development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein B
por: Fan, Jun, et al.
Publicado: (2012)

Screening for Cytomegalovirus during Pregnancy
por: Adler, Stuart P.
Publicado: (2011)

Enhanced anti-angiogenetic effect of transferrin receptor-mediated delivery of VEGF-trap in a glioblastoma mouse model
por: Zhao, Peng, et al.
Publicado: (2022)

Prevention of Maternal–Fetal Transmission of Cytomegalovirus
por: Adler, Stuart P.
Publicado: (2015)

Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice
por: Zhao, Peng, et al.
Publicado: (2022)

Anti-GRP-R monoclonal antibody antitumor therapy against neuroblastoma
por: Qiao, Jingbo, et al.
Publicado: (2022)

Cytomegalovirus Replication and the Host Immune Response
por: Lang, D. J., et al.
Publicado: (1976)

The Dynamics of Human Cytomegalovirus Replication in Vivo
por: Emery, Vincent C., et al.
Publicado: (1999)

Host Mitochondrial Requirements of Cytomegalovirus Replication
por: Monk, Chandler H., et al.
Publicado: (2020)

Human cytomegalovirus elicits fetal γδ T cell responses in utero
por: Vermijlen, David, et al.
Publicado: (2010)

Antibody therapies for the treatment of COVID-19
por: Ku, Zhiqiang, et al.
Publicado: (2020)

Cytomegalovirus Infections among African-Americans
por: Wilms, Isca R, et al.
Publicado: (2008)

Immunization of Rabbits with Recombinant Human Cytomegalovirus Trimeric versus Monomeric gH/gL Protein Elicits Markedly Higher Titers of Antibody and Neutralization Activity
por: Cui, Xinle, et al.
Publicado: (2019)

Natural infection by Zika virus but not DNA vaccination consistently elicits antibodies that compete with two potently neutralising monoclonal antibodies targeting distinct epitopes
por: Smith, Teresa C., et al.
Publicado: (2023)

Infection with cytomegalovirus is not associated with premature mortality
por: Adler, Stuart P., et al.
Publicado: (2011)

Inhibition by monensin of human cytomegalovirus DNA replication
por: Kaiser, C. J., et al.
Publicado: (1987)

Novel association of DJ-1 with HER3 potentiates HER3 activation and signaling in cancer
por: Zhang, Shu, et al.
Publicado: (2016)

Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016)

EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes
por: El Baba, Ranim, et al.
Publicado: (2023)

Intrinsic Immune Mechanisms Restricting Human Cytomegalovirus Replication
por: Schilling, Eva-Maria, et al.
Publicado: (2021)

Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination
por: Chen, Yuxin, et al.
Publicado: (2021)

Lack of autoantibody production associated with cytomegalovirus infection
por: Marshall, Beth C, et al.
Publicado: (2002)

SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector
por: Kapadia, Sagar U., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_dd4fubuf3m1lflr46pd8b82ut4